Lopid and Hyperparathyroidism - a phase IV clinical study of FDA data


Hyperparathyroidism is reported only by a few people who take Lopid.

The phase IV clinical study analyzes which people take Lopid and have Hyperparathyroidism. It is created by eHealthMe based on reports of 9,415 people who have side effects while taking Lopid from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 22, 2023

9,415 people reported to have side effects when taking Lopid.
Among them, 3 people (0.03%) have Hyperparathyroidism.

What is Lopid?

Lopid has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 9,577 Lopid users for its effectiveness, alternative drugs and more.

What is Hyperparathyroidism?

Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium) is found to be associated with 1,010 drugs and 431 conditions by eHealthMe.

Number of Lopid and Hyperparathyroidism reports submitted per year:

Could Lopid cause Hyperparathyroidism?

Gender of people who have Hyperparathyroidism when taking Lopid *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Hyperparathyroidism when taking Lopid *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 0.0 %
  • 60+: 66.67 %

Common drugs people take besides Lopid *:

  1. Aspirin: 2 people, 66.67%
  2. Zocor: 1 person, 33.33%
  3. Digoxin: 1 person, 33.33%
  4. Ismo: 1 person, 33.33%
  5. Imdur: 1 person, 33.33%
  6. Gemfibrozil: 1 person, 33.33%
  7. Furosemide: 1 person, 33.33%
  8. Flovent: 1 person, 33.33%
  9. Fish Oil: 1 person, 33.33%
  10. Dobutrex: 1 person, 33.33%

Common side effects people have besides Hyperparathyroidism *:

  1. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 66.67%
  2. Cough: 2 people, 66.67%
  3. Ventricular Extrasystoles (premature cardiac contraction): 2 people, 66.67%
  4. Cardiac Failure Congestive: 2 people, 66.67%
  5. Breathing Difficulty: 2 people, 66.67%
  6. Enlarged Heart: 2 people, 66.67%
  7. Renal Disorder (kidney disease): 2 people, 66.67%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 66.67%
  9. Cardioactive Drug Level Decreased: 1 person, 33.33%
  10. Cataract (clouding of the lens inside the eye): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lopid and have Hyperparathyroidism?

Check whether Hyperparathyroidism is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Hyperparathyroidism and when was it recovered:

Expand to all the drugs that have ingredients of gemfibrozil:

Alternative drugs to, pros and cons of Lopid:

Common Lopid side effects:

Browse all side effects of Lopid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hyperparathyroidism treatments and more:

COVID vaccines that are related to Hyperparathyroidism:

Common drugs associated with Hyperparathyroidism:

All the drugs that are associated with Hyperparathyroidism:

Common conditions associated with Hyperparathyroidism:

All the conditions that are associated with Hyperparathyroidism:

How the study uses the data?

The study uses data from the FDA. It is based on gemfibrozil (the active ingredients of Lopid) and Lopid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: